| 摘要 |
The cardiotoxic effects incident to the use of glycosidic anthracyclinones such as adriamycin, daunomycin, etc., in antitumor therapy, are substantially reduced by administering to a host undergoing such therapy, and effective amount of coenzymes Q, particularly Co-Q10 (Ubiquinone Q10). |
